Herein, we develop an engineered macrophage (eMac) which can locoregionally secrete IFN-γ in the tumor tissue through wireless remote control to induce their polarization toward M1 phenotype for cancer immunotherapy (Fig. 1). The gene discussed is IFNG; the disease is neoplasm.